Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07704957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The bacterial sexually transmitted infections (STIs) chlamydia, gonorrhea, and syphilis cause multiple adverse outcomes in women, and prevention strategies are critically needed. This project will determine the efficacy of doxycycline post-exposure prophylaxis (doxy PEP) to prevent STIs among women through a phase IV, open-label, randomized controlled trial.
Trial Details
NCT Number NCT07704957
Lead Sponsor Tulane University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), University of Alabama at Birmingham, Louisiana State University Health Sciences Center in New Orleans
Conditions
(from sponsor)		 Chlamydia Females, Gonorrhea Female, Syphilis Female, Adherence, Prophylaxis, Prevention
Enrollment 519 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov